Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT)

Haemophilia

Volumn 20, Issue 6, 2014, Pages 794-799

  Wu, R ^a   Zhang, J ^a   Sun, J ^b   Zhou, M ^c   Wu, J S ^d   Li, N ^b   Li, X ^c   Luke, K H ^e   Poon, M C ^f   Blanchette, V S ^g   Young, Nancy L ^h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c CHENGDU WOMEN S AND CHILDREN S CENTRAL HOSPITAL   (China)

^d ANHUI PROVINCIAL HOSPITAL   (China)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Haemophilia; Outcome measurement; Paediatrics; Quality of life

Indexed keywords

HEMATOLOGIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANADIAN HAEMOPHILIA OUTCOMES KIDS LIFE ASSESSMENT TOOL SIMPLIFIED CHINESE VERSION; CHILD; CHINA; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INTERRATER RELIABILITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEDSQL QUESTIONNAIRE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; TEST RETEST RELIABILITY; VALIDATION PROCESS; VALIDATION STUDY; FEMALE; HEALTH SURVEY; QUALITY OF LIFE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHINA; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; PUBLIC HEALTH SURVEILLANCE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84932082539     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12489     Document Type: Article

References (16)

1. Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
2. Poon MC, Luke KH. Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities. Haemophilia 2008; 14: 879-88.
3. Wu RH, Wu X, Zhang NN, Zhang JS, Zhao L, Su Y. Evaluation clinical data and current condition of children hemophilic patients in China. Chinese J Thromb Hemost 2008; 14: 116-20.
4. Tang L, Wu R, Sun J et al. Short-term lowdose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China. Haemophilia 2013; 19: 27-34.
5. Wu R, Luke KH, Poon MC et al. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China. Haemophilia 2011; 17: 70-4.
6. Young NL, Bradley CS, Blanchette V et al. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10(Suppl. 1): 34-43.
7. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer 2006; 47: 305-11.
8. Wu R, Zhang J, Luke KH et al. Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China. Health Qual Life Outcomes 2012; 10: 112.
9. Hao Y, Tian Q, Lu Y, Chai Y, Rao S. Psychometric properties of the Chinese version of the Pediatric Quality of Life Inventory 4.0 generic core scales. Qual Life Res 2010; 19: 1229-33.
10. Varni JW, Seid M, Knight TS, Uzark K, Szer IS. The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med 2002; 25: 175-93.
11. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-12.
12. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37: 126-39.
13. Fleiss JL. Reliability of measurement. In. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons, Inc., 1999: 1-32.
14. Young NL, St-Louis J, Burke T, Hershon L, Blanchette V. Cross-cultural validation of the CHO-KLAT and HAEMO-QoL-A in Canadian French. Haemophilia 2012; 18: 353-7.
15. He W, Wu RW, Wu X, He WW, Wu RH, Wu XY et al. Clinical analysis of diagnosis, treatment and bleeding pattern of 129 moderate and severe pre-school children hemophiliacs in China. Chin J Haematol 2012; 33: 426-8.
16. Wu R, Wu X, Zhang N et al. Modified long-term low-dose secondary prophylaxis for severe and moderate hemophilia A children with arthropathy: a single-center prospective study in China. Haemophilia, 2012; 18(Suppl. 3): 164.